While the cost of technology is decreasing, healthcare costs continue to skyrocket. How can we apply the gains from tech to healthcare?
Expanding on his keynote, Vijay Pande explains how machine learning techniques together with the recent explosion in data are leading to a new approach to prevention, allowing us to more effectively tackle some of the deadliest and costliest health challenges, including heart disease, cancer, and Type 2 diabetes.
Vijay Pande is a general partner at Andreessen Horowitz, where he leads the firm’s investments in companies at the cross-section of biology and computer science, including areas such as the application of computation, machine learning, and artificial intelligence in biology and healthcare and the application of novel transformative scientific advances. Previously, Vijay was the Henry Dreyfus Professor of Chemistry and and a professor of structural biology and computer science at Stanford University, where he also led a team of researchers pioneering computational methods and their application to medicine and biology, resulting in over 200 publications, two patents, and two novel drug treatments. Concurrently, he was the director of the biophysics program at Stanford, where he led a team of more than 50 faculty members. Under his leadership, it become one of top programs in the country.
Vijay is the founder of the Folding@home distributed computing project for disease research, which pushes the boundaries of the development and application of computer science techniques such as distributed systems, machine learning, and exotic computer architectures into biology and medicine. He is a cofounder of Globavir Biosciences, which discovered cures for dengue fever and Ebola. In his teens, he was the first employee at video game startup Naughty Dog Software, maker of Crash Bandicoot. His awards include the DeLano Prize in Computation, a Guinness world record for Folding@home, ACS Thomas Kuhn Paradigm Shift Award, and an MIT TR100 recognition. Vijay serves on the boards of Apeel Sciences, Freenome, Omada Health, PatientPing, and Rigetti Computing—all Andreessen Horowitz portfolio companies. He also leads the firm’s investments in Benchling, Cardiogram, SolveBio, TL Biolabs, twoXAR, Q.bio, and uBiome. Vijay holds a BA in physics from Princeton University and a PhD in physics from MIT.
©2017, O'Reilly Media, Inc. • (800) 889-8969 or (707) 827-7019 • Monday-Friday 7:30am-5pm PT • All trademarks and registered trademarks appearing on oreilly.com are the property of their respective owners. • email@example.com